Is being a Pharmacy Benefits Manager
at risk from AI?

Not in the foreseeable future, but the role will transform significantly. AI is already automating routine prior authorizations, claims analysis, and formulary recommendations—tasks that once consumed 40-50% of a PBM's day. What AI cannot do is negotiate multi-million-dollar contracts with manufacturers, interpret ambiguous CMS guidance, or make judgment calls that balance clinical efficacy against plan solvency and member satisfaction. The PBMs who survive will be those who shift from operational execution to strategic oversight, using AI as a force multiplier rather than competing with it on speed.

Disruption is already underway. Major PBMs and health plans are deploying AI for utilization management and claims adjudication today, with measurable reductions in manual review time. Over the next 2-3 years, expect AI to handle 70-80% of straightforward prior authorizations and generate most routine analytics reports. The bigger shift—AI assisting with formulary strategy and regulatory compliance—will unfold over 3-5 years as models improve at reasoning through multi-constraint optimization problems. The roles most at risk are junior analysts doing repetitive review work; senior managers focused on negotiation, compliance, and program design face less immediate pressure.

Double down on what AI cannot do: negotiation, regulatory interpretation, and strategic program design. Specifically, deepen your expertise in value-based contracting, biosimilar adoption strategies, and emerging payment models like outcomes-based rebates. Learn enough about AI tools to validate their outputs—you do not need to code, but you should understand how to prompt analytics platforms and spot when a model is hallucinating or missing context. Finally, cultivate influence across clinical, actuarial, and legal teams; the integrator role is automation-resistant because it requires trust and organizational knowledge that does not transfer to software.

Salaries will likely polarize. Junior PBM roles focused on manual review and data entry will see downward pressure as AI absorbs that work, potentially compressing entry-level compensation by 10-20% over the next few years. Senior managers who own strategic negotiations, regulatory strategy, or clinical program innovation will see stable or growing compensation, as their judgment becomes more valuable when routine work is automated. The key differentiator will be demonstrable impact: if you can show you saved $5M through a creative manufacturer contract or successfully navigated a CMS audit, you will command a premium.

Senior managers are significantly safer. Junior PBMs often spend the majority of their time on tasks AI handles well: processing prior authorizations, generating utilization reports, and maintaining formulary databases. These roles will shrink or evolve into AI oversight positions with lower headcount. Senior managers, by contrast, spend their time negotiating contracts, interpreting regulatory gray areas, designing clinical programs, and managing cross-functional initiatives—work that requires judgment, relationships, and accountability. If you are early in your PBM career, prioritize getting exposure to strategic projects and stakeholder management as quickly as possible.

Somewhat. PBMs in major health insurance hubs (Indianapolis, Hartford, Minneapolis, Chicago) have more opportunities to move into strategic roles at large payers if their current employer automates aggressively. Remote PBMs may face stiffer competition as geographic barriers fall, but the role itself is already largely remote-friendly, so location matters less than employer type. Working for a large, sophisticated PBM or health plan that invests in AI gives you earlier exposure to the tools and strategic pivots that will define the next decade; smaller regional players may lag, giving you more time but less upskilling opportunity.

The biggest mistake is clinging to operational tasks that AI will inevitably do better. Some PBMs take pride in their speed at manual prior auth review or their ability to build complex Excel models—but these are exactly the skills AI is replacing. The second mistake is ignoring AI entirely, assuming the role is too complex or regulated to change. In reality, even heavily regulated functions like formulary management are being augmented by AI, and managers who cannot work alongside these tools will be sidelined. The winning move is to treat AI as a junior analyst you manage: let it handle the grunt work, focus your time on judgment calls and stakeholder relationships, and position yourself as the strategic leader who delivers outcomes AI cannot.